A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease (Q21146622)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease |
scientific article |
Statements
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease (English)
0 references
Stephen M Strittmatter
Stephen M
Strittmatter
1 reference
1 reference
Haakon B Nygaard
1 reference
Allison F Wagner
1 reference
Garrett S Bowen
1 reference
Susan P Good
1 reference
Martha G MacAvoy
1 reference
Kurt A Strittmatter
1 reference
Adam C Kaufman
1 reference
Brian J Rosenberg
1 reference
Tomoko Sekine-Konno
1 reference
Pradeep Varma
1 reference
Kewei Chen
1 reference
Anthony J Koleske
1 reference
Christopher H van Dyck
1 reference
2015
0 references
7
0 references
1
0 references
35
0 references
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference